Dare Bioscience (DARE) news
Recent news
Dare Bioscience - Files for resale of up to 8,934,345 shares of common stock - SEC filing
Daré Bioscience, Inc. (NASDAQ: DARE) has filed with the U.S. Securities and Exchange Commission (SEC) to resell up to 8,934,345 shares of its common stock, according to recent SEC filings. The filing, dated August 24, 2026, is in the form of Schedule 13G, which typically discloses significant…
AInvest Wire · 4d agoDaré Bioscience announces pricing of $6.0 million registered direct offering priced at-the-market under Nasdaq rules
Daré Bioscience, Inc. (NASDAQ: DARE) has announced the pricing of a $6.0 million registered direct offering under Nasdaq rules. The offering includes the sale of 10,000,000 shares of the company’s common stock and warrants to purchase up to 10,000,000 shares of common stock. Each warrant is…
AInvest Wire · Aug 14, 2026Daré Bioscience Shares Climb 20%, Set to Receive First of $180M in Potential Payments
AInvest Wire · Oct 16, 2023Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.